Stockscreener 앱 받기
4.06
1.00%
0.04
시간 외 거래:
4.07
0.01
+0.25%
전일 마감가:
$4.02
열려 있는:
$3.98
하루 거래량:
2.10M
Relative Volume:
0.46
시가총액:
$495.50M
수익:
$44.55M
순이익/손실:
$-83.78M
주가수익비율:
-5.2225
EPS:
-0.7774
순현금흐름:
$-52.99M
1주 성능:
+0.74%
1개월 성능:
+2.53%
6개월 성능:
-28.40%
1년 성능:
+36.24%
1일 변동 폭
$3.961
$4.17
1주일 범위
$3.96
$4.2577
52주 변동 폭
$2.12
$7.55
Aquestive Therapeutics Inc Stock (AQST) Company Profile
명칭
Aquestive Therapeutics Inc
전화
908-941-1900
주소
30 TECHNOLOGY DRIVE, WARREN, NJ
Compare AQST vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
4.06 | 490.62M | 44.55M | -83.78M | -52.99M | -0.7774 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.11 | 56.96B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
115.99 | 49.54B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.23 | 45.90B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.44 | 34.48B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
527.00 | 23.24B | 3.18B | 1.33B | 1.04B | 27.90 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2024-12-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-05-10 | 개시 | Leerink Partners | Outperform |
| 2024-04-11 | 개시 | Piper Sandler | Overweight |
| 2024-03-28 | 개시 | Raymond James | Outperform |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2019-04-22 | 개시 | H.C. Wainwright | Buy |
| 2019-01-03 | 개시 | Lake Street | Buy |
| 2018-08-20 | 개시 | JMP Securities | Mkt Outperform |
| 2018-08-20 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Aquestive Therapeutics Inc 주식(AQST)의 최신 뉴스
Bronstein, Gewirtz & Grossman LLC Urges Aquestive - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors - GlobeNewswire
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT - GlobeNewswire
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2025 earnings call transcript - MSN
Lake Street adjusts Aquestive Therapeutics, Inc. (AQST) valuation model on expected approval delay - MSN
AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Volume Recap: Can Aquestive Therapeutics Inc grow without external fundingTrade Ideas & Verified Swing Trading Watchlist - baoquankhu1.vn
Aquestive Therapeutics Faces Investor Lawsuit Over Alleged FDA Approval Misrepresentations for Anaphylm - TipRanks
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Analyst Slashed Price Target: Levi & Korsinsky - PR Newswire
AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - ChartMill
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AQST Shareholder Alert: Aquestive Therapeutics, Inc. Securities - GuruFocus
AQST Shareholder Alert: Aquestive Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm - PR Newswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
ROSEN Law Firm Encourages Aquestive Therapeutics Investors to Seek Counsel Before Deadline - National Today
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure ... - Caledonian Record
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. - GlobeNewswire
AQST INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026 – Company AnnouncementFT.com - Financial Times
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Aquestive Therapeutics Maps Risky Path to ANNAFILM Launch - TipRanks
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AQST SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026 - TMX Newsfile
What’s the RSI of Aquestive Therapeutics Inc. stockJuly 2025 Gainers & Safe Entry Momentum Stock Tips - mfd.ru
AQST UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 (2026-03-14) - Seeking Alpha
ROSEN Law Firm Encourages Aquestive Therapeutics Investors to Secure Counsel Before Deadline - National Today
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to ... - Bluefield Daily Telegraph
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Aquestive - GlobeNewswire
AQST Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline - GlobeNewswire
Aquestive Therapeutics SVP Cioffi sells $105k in shares - Investing.com Nigeria
AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
2026-03-13 | AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:AQST | Press Release - Stockhouse
Aquestive Therapeutics: Post-CRL Risk, Timeline, And Valuation (NASDAQ:AQST) - Seeking Alpha
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesAQST - Sahm
AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026 - Sahm
Class Action Lawsuit Filed Against Aquestive Therapeutics - Intellectia AI
Aquestive Therapeutics Investors Eligible for Securities Fraud Lawsuit - National Today
AQST Lawsuit Alleges Analyst Slashed Price TargetAQUESTIVE THERAPEUTICS, INC. Investors Face Losses Following Analyst Slashed Price Target: SueWallSt - Stock Titan
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive ... - Bluefield Daily Telegraph
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AQST Stock Price, Quote & Chart | AQUESTIVE THERAPEUTICS INC (NASDAQ:AQST) - ChartMill
Aquestive therapeutics chief legal officer Braender sells $167k in stock - Investing.com Canada
Aquestive Therapeutics SVP Cioffi sells $105k in shares By Investing.com - Investing.com Canada
Aquestive Therapeutics CEO Barber sells $753,965 in stock By Investing.com - Investing.com Canada
Aquestive Therapeutics CEO Barber sells $753,965 in stock - Investing.com
Insider Selling: Aquestive Therapeutics (NASDAQ:AQST) COO Sells 45,791 Shares of Stock - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) Insider Peter Boyd Sells 29,814 Shares - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) SVP Melina Cioffi Sells 25,311 Shares - MarketBeat
Aquestive Therapeutics Inc (AQST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.77%
자본화:
|
볼륨(24시간):